Jong Ho Cho

Medicine and Dentistry

1. Non Small Cell Lung Cancer 100%
2. Lung Cancer 97%
3. Overall Survival 68%
4. Lobectomy 52%
5. Recurrent Disease 48%
6. Esophagectomy 47%
7. Esophageal Squamous Cell Carcinoma 47%
8. Neoplasm 42%
9. Pneumonectomy 39%
10. Chemoradiotherapy 35%
11. Esophageal Cancer 33%
12. Recurrence Free Survival 30%
13. Hazard Ratio 27%
14. Lung 25%
15. Video-Assisted Thoracoscopic Surgery 24%
16. Prognostic Factor 23%
17. Retroperitoneal Lymph Node Dissection 22%
18. Lung Adenocarcinoma 22%
19. Tumor 20%
20. Lymph Node Metastasis 19%
21. Clinical Stage 19%
22. Cohort Analysis 18%
23. Malignant Neoplasm 18%
24. Diseases 18%
25. Survival Rate 18%
26. Epidermal Growth Factor Receptor 17%
27. Computer Assisted Tomography 17%
28. Disease Free Survival 16%
29. Thorax Surgery 15%
30. Lymph Node 14%
31. Prevalence 13%
32. Colorectal Carcinoma 13%
33. Metastasectomy 13%
34. Non-Small Cell Lung Cancer 13%
35. Lung Function 12%
36. Adjuvant Chemotherapy 12%
37. Long Term Survival 11%
38. Chemoradiation Therapy 11%
39. Thymus Cancer 10%
40. Epithelioma 10%
41. Circulating Tumor DNA 10%
42. Surgery 10%
43. Proportional Hazards Model 10%
44. Median Follow Up 10%
45. Retrospective Cohort Study 10%
46. Radiation Therapy 10%
47. Adenocarcinoma 10%
48. Neoadjuvant Therapy 10%
49. Suture 9%
50. Thoracic Duct 9%